Drug profile · INN
pimecrolimus
ELIDEL
- US status
- approved
- Patents linked
- 2
- News articles
- 0
Quick answer
pimecrolimus (ELIDEL) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN pimecrolimus
Brand ELIDEL
Route TOPICAL
Formulation CREAM
Related patents
Search patents →Frequently asked questions
What is pimecrolimus?
pimecrolimus (ELIDEL) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for pimecrolimus?
ELIDEL is a marketed brand name for pimecrolimus. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pimecrolimus?
pimecrolimus has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.